UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000030938 |
|---|---|
| Receipt number | R000035329 |
| Scientific Title | A phase II study of Nivolumab re-challenge therapy after VEGF inhibitor therapy in patients with advanced non-small cell lung cancer. Gunma-Ibaraki-Fukushima-Tochigi (GIFT) group study |
| Date of disclosure of the study information | 2018/01/24 |
| Last modified on | 2023/01/26 16:41:05 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2018/01/22 18:39:48 | ||
| 2 | Update | 2018/01/24 10:38:08 | Organization |
|
| 3 | Update | 2022/08/03 14:29:59 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Organization Organization Division name Division name Zip code Address Address TEL Last name of contact person Last name of contact person Zip code Address Organization Organization Address Address Tel |
|
| 4 | Update | 2023/01/26 16:41:05 | Date of IRB Last follow-up date |
